Improving Resilience and Equity in Cancer Screening: Lessons from COVID-19 and Beyond

In the coming months, the President’s Cancer Panel will conduct a series of meetings to discuss the effects of COVID-19 on cancer screening across four cancer types—cervical cancer, breast cancer, colorectal cancer, and lung cancer. The goal is to explore specific issues deemed critical to the National Cancer Program and develop strategies to accelerate improvements in the area of cancer screening across these four tumor types and in cancer screening in general.

The Panel meeting will be webcast and will include an opportunity for stakeholders and the public to provide input and ask questions during the public comment portion of the meeting. Information on the dates and times of the meeting is below.

Virtual Meeting Dates and Times

Lung Cancer Day 1: October 26, 2020, 1:00 – 5:00 PM EDT
Lung Cancer Day 2: October 28, 2020, 1:00 – 5:00 PM EDT

Colorectal Cancer Day 1: November 2, 2020, 1:00 – 5:00 PM EST
Colorectal Cancer Day 2: November 4, 2020, 1:00 – 5:00 PM EST

Cervical Cancer Day 1: November 9, 2020, 1:00 – 5:00 PM EST
Cervical Cancer Day 2, November 10, 2020, 1:00 – 5:00 PM EST

Breast Cancer Day 1: November 16, 2020, 1:00 – 5:00 PM EST
Breast Cancer Day 2, November 18, 2020, 1:00 – 5:00 PM EST

Please also feel free to share the details of the webcast with any colleagues or constituents that may be interested. Registration is not necessary, and the webcast is open to the public without charge

On the day of the meeting please use this link to view the webcast:
https://nci.rev.vbrick.com/#/webcasts/presidentscancerpanel

For additional information about the Panel, please refer to the official Panel Web site: http://prescancerpanel.cancer.gov